NEW YORK (GenomeWeb News) - The US Food and Drug Administration’s regulatory approach toward laboratory-developed tests unfairly favors some manufacturers, and this imbalance was not sufficiently discussed during a recent meeting of the HHS Secretary’s Advisory Committee for Genetics, Health, and Society, according to Kathy Hudson, director of Johns Hopkins University’s Genetic Public Policy Center.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.